FDA has approved a new Alzheimer’s drug despite mixed trial results | Science News

FDA has approved a new Alzheimer’s drug despite mixed trial results | Science News: A new Alzheimer's treatment slows progression of the disease, the drug’s developers say. But some researchers question its effectiveness.